Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Stephen Padilla, 4 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 3 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

Mobile phones may be used to assess hearing loss prevalence

Tristan Manalac
31 Jul 2020

The use of mobile phones is plausible for the measurement of hearing thresholds and may be helpful in large-scale, epidemiologic surveys, according to a recent study.

“Unsupervised self-tests require additional quality control based on the test duration and connection status of the headphones. Moreover, ambient noise and calibration method introduce additional bias,” researchers said. “Despite this, hearing thresholds measured by means of mobile devices were congruent with data reported in the literature.”

Researchers examined 733,716 tests collected from 236,716 devices across 212 countries. Almost all tests (99.3 percent) performed the hearing threshold measurement at the fundamental frequencies of 0.25, 0.5, 1, 2, 4, 6, and 8 kHz. After removing tests that were performed without connected headphones, 86.8 percent (n=637,169) remained.

Hearing loss, defined as a mean hearing threshold >25 dB in the better hear or 0.5–4 kHz, was most common for Pakistan (37.8 percent), Bangladesh (32.2 percent), and India (28.5 percent). The lowest prevalence rates were reported for Taiwan (9.6 percent), Finland (9.8 percent), and South Korea (10.2 percent). [J Med Internet Res 2020;22:e17238]

The global prevalence rate of hearing loss was 15.6 percent. Of the 212 countries assessed, 74 met the recommended sample size of 90 tests per country.

The effect of ambient noise was evaluated in 30,119 hearing tests conducted. The researchers found that ambient noise had an overall effect of 3.78 dB on hearing threshold, which corresponded to a 4.16-percent drop in country-specific prevalence rates.

Ambient noise peaked in Pakistan, Bangladesh, and India, which saw a 10.7-, 8.6-, and 6.2-percent decrease in the prevalence of hearing loss, respectively. Regardless, hearing loss remained most prevalent in these countries.

Notably, researchers saw that the device model was an important factor to consider. Hearing thresholds significantly differed among device models (p=0.01), which resulted directly from the biological calibration method. However, adjusting for the model changed the mean hearing threshold per country by only –0.07 dB.

“The required sample size was not reached in a significant number of African countries. In the poorest countries, the limiting factor is access to mobile devices and the internet,” the researchers said. “The same situation may also occur in countries with significant social stratification, contributing to the lower prevalences of hearing loss resulting from a lack of data from the poorer part of the population.”

Participants were recruited through the Hearing Test app, which was available for download on the Google Play store, for Android devices. Additionally, only users of devices for which the calibration coefficients had been previously determined were eligible for inclusion. All hearing tests were conducted using headphones bundled with the purchase of the mobile devices.

“This paper presents global country-specific prevalences of hearing loss based on self-tests carried out by Android users,” the researchers said. “Hearing tests on mobile devices may be a valid tool in epidemiological studies carried out on a large scale.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Stephen Padilla, 4 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 3 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.